The biggest question for me is whether this will hold up with variants, particularly delta. My understanding of the data from the UK is that the effectiveness of the full two-dose regimen against delta is quite good, but the single dose less so. There are a lot of unknowns here, but if there is greater chance of vaccine escape, we could be playing with fire.